Graves' disease
Not recruitingStudy on the Effects of Satralizumab for Patients with Moderate-to-Severe Thyroid Eye Disease
- Disease:Graves' disease
- Substances:–
Germany- Participants:18–64 years · 65+ years
- Sponsor:F. Hoffmann-La Roche AG
Rare diseases
Investigational molecules
Locations
Back to Germany529 clinical trials in Freiburg Im Breisgau, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on breast cancer, non-small cell lung cancer, and colon cancer treatments. Studies evaluating new therapeutic approaches for both early-stage and advanced cancers.
Emphasis on targeted therapies and combination treatments to improve patient outcomes.
Research into treatments for psoriatic arthritis, rheumatoid arthritis, and Sjögren's disease. Studies evaluating novel biologics and targeted therapies.
Focus on improving disease control and quality of life for patients with chronic autoimmune conditions.
Clinical investigations of treatments for spinal muscular atrophy, sickle cell disease, and primary sclerosing cholangitis. Studies aimed at developing innovative therapies.
Dedicated to finding breakthrough treatments for challenging rare conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.